⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
MLTX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that MoonLake Immunotherapeutics Stockholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MLTX
Pomerantz LLP Informs Investors of Class Action Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
Contact Levi & Korsinsky by December 15, 2025 to Join Class Action Against MoonLake Immunotherapeutics (MLTX)
accessnewswire.com
MLTX
MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit
prnewswire.com
MLTX
Investors in MoonLake Immunotherapeutics (MLTX): Protect Your Rights - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
MLTX CLASS ACTION REMINDER: MoonLake Immunotherapeutics Investors Are Encouraged to Act Before The Upcoming December 15 Legal Deadline - Contact BFA Law
accessnewswire.com
MLTX
Contact Levi & Korsinsky by December 15, 2025 to Join Class Action Against MoonLake Immunotherapeutics (MLTX)
accessnewswire.com
MLTX
Tune Into the SueWallSt Podcast: MoonLake Immunotherapeutics (MLTX) Lawsuit Explained
accessnewswire.com
MLTX
Class Action Filed Against MoonLake Immunotherapeutics (MLTX) Over Securities Violations - Contact Levi & Korsinsky Today
accessnewswire.com
MLTX
Pomerantz LLP Highlights Class Action Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX